Adverse events reporting of edaravone: a real-world analysis from FAERS database

Adverse events reporting of edaravone: a real-world analysis from FAERS database

Abstract For individuals with amyotrophic lateral sclerosis (ALS), intravenous edaravone is approved as a disease-modifying medication; yet, there have been many reports of adverse events (AEs). We examined the AEs associated with edaravone in this study using actual data from the FDA’s (Food and Dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Shang, Jie Zhou, Junchang Ye, Maohua Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Scientific Reports
Subjects:
Edaravone
Real-world data analysis
Adverse events
Pharmacovigilance
Disproportionality analysis
Online Access:https://doi.org/10.1038/s41598-025-92605-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-92605-5

Similar Items